Skip to main content

and
  1. Article

    Open Access

    Correction: A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation

    E. Grassilli, F. Pisano, A. Cialdella, S. Bonomo, C. Missaglia, M. G. Cerrito in Oncogene (2024)

  2. Article

    Open Access

    Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study

    Tregs are able of suppressing tumor-specific effector cells, such as lymphocytes CD8+, CD4+ and Natural Killer cells. Different drugs, especially different schedules of administration, like metronomic chemothe...

    F. F. Pepe, M. E. Cazzaniga, S. Baroni, F. Riva, F. Cicchiello, S. Capici in BMC Cancer (2022)

  3. Article

    Open Access

    A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation

    Bruton’s tyrosine kinase (BTK) is essential for B-cell proliferation/differentiation and it is generally believed that its expression and function are limited to bone marrow-derived cells. Here, we report the ...

    E Grassilli, F Pisano, A Cialdella, S Bonomo, C Missaglia, M G Cerrito in Oncogene (2016)

  4. Article

    35th Annual Meeting of the European Association for the Study of Diabetes

    A. Melander, J. Olsson, G. Lindberg, A. Salzman, T. Howard, P. Stang in Diabetologia (1999)